Metabolic profile of oxazepam and related benzodiazepines: clinical and forensic aspects

References

• 1980. Systematic review of the benzodiazepines. Guidelines for data sheets on diazepam, chlordiazepoxide, medazepam, clorazepate, lorazepam, oxazepam, temazepam, triazolam, nitrazepam, and flurazepam. Committee on the review of medicines. Br Med J. 280:910–912.
   PubMedGoogle Scholar
• al-Hadidi KA, Oliver JS. 1995. Stability of temazepam in blood. Sci Justice. 35:105–108.
   PubMed Web of Science ®Google Scholar
• Altamura AC, Moliterno D, Paletta S, Maffini M, Mauri MC, Bareggi S. 2013. Understanding the pharmacokinetics of anxiolytic drugs. Exp Opin Drug Metabol Toxicol. 9:423–440.
   PubMed Web of Science ®Google Scholar
• Alvan G, Odar-Cederlof I. 1978. The pharmacokinetic profile of oxazepam. Acta Psychiat Scand. 58:47–55.
   Google Scholar
• Aso Y, Yoshioka S, Shibazaki T, Uchiyama M. 1988. The kinetics of the racemization of oxazepam in aqueous solution. ChemPharm Bull. 36:1834–1840.
   PubMed Web of Science ®Google Scholar
• Atanasov VN, Stoykova S, Runiov A, Dimitrova T, Aleksandrova D, Tsakovski S, Mitewa M. 2012. Stability of diazepam in blood samples at different storage conditions and in the presence of alcohol. Forensic Sci Int. 215:159–163.
   PubMed Web of Science ®Google Scholar
• Baselt RC. 2014. Disposition of drugs and toxic chemicals in man. Seal Beach (CA): Biomedical Publications.
   Google Scholar
• Boudinot FD, Homon CA, Jusko WJ, Ruelius HW. 1985. Protein binding of oxazepam and its glucuronide conjugates to human albumin. Biochem Pharmacol. 34:2115–2121.
   PubMed Web of Science ®Google Scholar
• Boxenbaum HG, Geitner KA, Jack ML, Dixon WR, Spiegel HE, Symington J, Christian R, Moore JD, Weissman L, Kaplan SA. 1977. Pharmacokinetic and biopharmaceutic profile of chlordiazepoxide HC1 in healthy subjects: single-dose studies by the intravenous, intramuscular, and oral routes. J Pharmacokinet Biopharm. 5:3–23.
   PubMedGoogle Scholar
• Breimer DD. 1979. Pharmacokinetics and metabolism of various benzodiazepines used as hypnotics. Br J Clin Pharmacol. 8:7S–13S.
   PubMed Web of Science ®Google Scholar
• Brunton LL, Knollman BC, Hilal-Dandan R. 2017. Goodman & Gilman’s – the pharmacological basis of therapeutics. New York: McGraw-Hill – Medical Publishing Division.
   Google Scholar
• Chauvet A. 1995. Characterization of lorazepam and oxazepam by the thermal behavior of their degradation product. Ann Pharm Fr. 53:256–260.
   PubMedGoogle Scholar
• Chin PK, Jensen BP, Larsen HS, Begg EJ. 2011. Adult age and ex vivo protein binding of lorazepam, oxazepam and temazepam in healthy subjects. Br J Clin Pharmacol. 72:985–989.
   PubMed Web of Science ®Google Scholar
• Chouinard G, Lefko-Singh K, Teboul E. 1999. Metabolism of anxiolytics and hypnotics: benzodiazepines, buspirone, zoplicone, and zolpidem. Cell Mol Neurobiol. 19:533–552.
   PubMed Web of Science ®Google Scholar
• Court MH, Duan SX, Guillemette C, Journault K, Krishnaswamy S, Von Moltke LL, Greenblatt DJ. 2002. Stereoselective conjugation of oxazepam by human UDP-glucuronosyltransferases (UGTs): S-oxazepam is glucuronidated by UGT2B15, while R-oxazepam is glucuronidated by UGT2B7 and UGT1A9. Drug Metab Disp. 30:1257–1265.
   PubMed Web of Science ®Google Scholar
• Court MH, Hao Q, Krishnaswamy S, Bekaii-Saab T, Al-Rohaimi A, von Moltke LL, Greenblatt DJ. 2004. UDP-glucuronosyltransferase (UGT) 2B15 pharmacogenetics: UGT2B15 D85Y genotype and gender are major determinants of oxazepam glucuronidation by human liver. J Pharmacol Exp Ther. 310:656–665.
   PubMed Web of Science ®Google Scholar
• Dinis-Oliveira RJ, Vieira DN, Magalhães T. 2016. Guidelines for collection of biological samples for clinical and forensic toxicological analysis. Forensic Sci Res. 1:42–51.
   PubMedGoogle Scholar
• Dinis-Oliveira RJ. 2014. Metabolomics of drugs of abuse: a more realistic view of the toxicological complexity. Bioanalysis. 6:3155–3159.
   PubMed Web of Science ®Google Scholar
• Dinis-Oliveira RJ. 2015. Metabolomics of cocaine: implications in toxicity. Toxicol Mech Methods. 25:494–500.
   PubMed Web of Science ®Google Scholar
• Dinis-Oliveira RJ. 2016a. Metabolomics of Δ9-tetrahydrocannabinol: implications in toxicity. Drug Metab Rev. 48:80–87.
   PubMed Web of Science ®Google Scholar
• Dinis-Oliveira RJ. 2016b. Oxidative and non-oxidative metabolomics of ethanol. Curr Drug Metab. 17:327–335.
   PubMed Web of Science ®Google Scholar
• Dinis-Oliveira RJ. 2017. Metabolic profile of flunitrazepam: clinical and forensic toxicological aspects. Drug Metab Lett. [Epub ahead of print]. doi: 10.2174/1872312811666170407164216.
   PubMedGoogle Scholar
• Diwan BA, Rice JM, Ward JM. 1986. Tumor-promoting activity of benzodiazepine tranquilizers, diazepam and oxazepam, in mouse liver. Carcinogenesis. 7:789–794.
   PubMed Web of Science ®Google Scholar
• Dixon RB, Mbeunkui F, Wiegel JV. 2015. Stability study of opioids and benzodiazepines in urine samples by liquid chromatography tandem mass spectrometry. J Anal Sci Technol. 6:17.
   Google Scholar
• Dusci LJ, Good SM, Hall RW, Ilett KF. 1990. Excretion of diazepam and its metabolites in human milk during withdrawal from combination high dose diazepam and oxazepam. Br J Clin Pharmacol. 29:123–126.
   PubMed Web of Science ®Google Scholar
• El Mahjoub A, Staub C. 2000. Stability of benzodiazepines in whole blood samples stored at varying temperatures. J Pharm Biomed Anal. 23:1057–1063.
   PubMed Web of Science ®Google Scholar
• Fehske KJ, Muller WE, Wollert U. 1981. The location of drug binding sites in human serum albumin. Biochem Pharmacol. 30:687–692.
   PubMed Web of Science ®Google Scholar
• Frigerio A, Baker KM, Belvedere G. 1973. Gas chromatographic degradation of several drugs and their metabolites. Anal Chem. 45:1846–1851.
   PubMed Web of Science ®Google Scholar
• Fu S, Lewis J, Wang H, Keegan J, Dawson M. 2010. A novel reductive transformation of oxazepam to nordiazepam observed during enzymatic hydrolysis. J Anal Toxicol. 34:243–251.
   PubMed Web of Science ®Google Scholar
• Ghabrial H, Desmond PV, Watson KJ, Gijsbers AJ, Harman PJ, Breen KJ, Mashford ML. 1986. The effects of age and chronic liver disease on the elimination of temazepam. Eur J Clin Pharmacol. 30:93–97.
   PubMed Web of Science ®Google Scholar
• Golan DE, Armstrong EJ, Armstrong AW. 2017. Principles of pharmacology: the pathophysiologic basis of drug therapy. Philadelphia: Lippincott Williams & Wilkins.
   Google Scholar
• Greenblatt DJ, Allen MD, Harmatz JS, Shader RI. 1980. Diazepam disposition determinants. Clin Pharmacol Ther. 27:301–312.
   PubMed Web of Science ®Google Scholar
• Greenblatt DJ, Divoll M, Harmatz JS, Shader RI. 1980. Oxazepam kinetics: effects of age and sex. J Pharmacol Exp Ther. 215:86–91.
   PubMed Web of Science ®Google Scholar
• Greenblatt DJ, Murray TG, Audet PR, Locniskar A, Koepke HH, Walker BR. 1983. Multiple-dose kinetics and dialyzability of oxazepam in renal insufficiency. Nephron. 34:234–238.
   PubMed Web of Science ®Google Scholar
• Greenblatt DJ, Shader RI, Koch-Weser J. 1975. Pharmacokinetics in clinical medicine: oxazepam versus other benzodiazepines. Dis Nerv Syst. 36:6–13.
   PubMedGoogle Scholar
• Greenblatt DJ. 1981. Clinical pharmacokinetics of oxazepam and lorazepam. Clin Pharmacokinet. 6:89–105.
   PubMed Web of Science ®Google Scholar
• Griffin CE III, Kaye AM, Bueno FR, Kaye AD. 2013. Benzodiazepine pharmacology and central nervous system-mediated effects. Ochsner J. 13:214–223.
   PubMedGoogle Scholar
• Griffin RJ, Burka LT, Cunningham ML. 1995. Activity of hepatic drug metabolizing enzymes following oxazepam-dosed feed treatment in B6C3F1 mice. Toxicol Lett. 76:251–256.
   PubMed Web of Science ®Google Scholar
• Griffin RJ, Burka LT, Demby KB. 1995. Oxidative biotransformation of oxazepam to reactive and nonreactive products in rat, mouse and human microsomes. Hum Exp Toxicol. 14:779–786.
   PubMed Web of Science ®Google Scholar
• Griffin RJ, Burka LT. 1995. Metabolism and elimination of oxazepam in F344 rats. Drug Metab Disp. 23:232–239.
   PubMed Web of Science ®Google Scholar
• Halapy E, Kreiger N, Cotterchio M, Sloan M. 2006. Benzodiazepines and risk for breast cancer. Ann Epidemiol. 16:632–636.
   PubMed Web of Science ®Google Scholar
• He X, Hesse LM, Hazarika S, Masse G, Harmatz JS, Greenblatt DJ, Court MH. 2009. Evidence for oxazepam as an in vivo probe of UGT2B15: oxazepam clearance is reduced by UGT2B15 D85Y polymorphism but unaffected by UGT2B17 deletion. Br J Clin Pharmacol. 68:721–730.
   PubMed Web of Science ®Google Scholar
• Hoffman RS, Howland MA, Lewin NA, Nelson LS, Goldfrank LR. 2014. Goldfrank’s toxicologic emergencies. New York: McGraw-Hill Education.
   Google Scholar
• Howland RH. 2016. Safety and abuse liability of oxazepam: is this benzodiazepine drug underutilized? J Psychosoc Nurs Ment Health Serv. 54:22–25.
   PubMed Web of Science ®Google Scholar
• Inomata S, Nagashima A, Itagaki F, Homma M, Nishimura M, Osaka Y, Okuyama K, Tanaka E, Nakamura T, Kohda Y, et al. 2005. CYP2C19 genotype affects diazepam pharmacokinetics and emergence from general anesthesia. Clin Pharmacol Ther. 78:647–655.
   PubMed Web of Science ®Google Scholar
• Iqbal U, Nguyen PA, Syed-Abdul S, Yang HC, Huang CW, Jian WS, Hsu MH, Yen Y, Li YC. 2015. Is long-term use of benzodiazepine a risk for cancer? Medicine. 94:e483.
   PubMed Web of Science ®Google Scholar
• Japp M, Garthwaite K, Geeson AV, Osselton MD. 1988. Collection of analytical data for benzodiazepines and benzophenones. J Chromatogr. 439:317–339.
   PubMed Web of Science ®Google Scholar
• Karch SB, Drummer OH. 2016. Karch’s pathology of drug abuse. Boca Raton: CRC Press, Taylor & Francis Group.
   Google Scholar
• Karmali RA, et al. 1979. The influence of diazepam administration in rats bearing the R3230AC mammary carcinoma. Prostaglandins Med. 3:193–198.
   PubMedGoogle Scholar
• Katzung BG, Trevor AJ. 2015. Basic & clinical pharmacology. New York: McGraw-Hill.
   Google Scholar
• Kelly E, Darke S, Ross J. 2004. A review of drug use and driving: epidemiology, impairment, risk factors and risk perceptions. Drug Alcohol Rev. 23:319–344.
   PubMed Web of Science ®Google Scholar
• Kleber RJ. 1980. Ketazolam compared to diazepam and placebo in the treatment of anxiety. J Int Med Res. 8:439–445.
   PubMed Web of Science ®Google Scholar
• Klotz U, Avant GR, Hoyumpa A, Schenker S, Wilkinson GR. 1975. The effects of age and liver disease on the disposition and elimination of diazepam in adult man. J Clin Invest. 55:347–359.
   PubMed Web of Science ®Google Scholar
• Knowles JA, Ruelius HW. 1972. Absorption and excretion of 7-chloro-1,3-dihydro-3-hydroxy-5-phenyl-2H-1,4-benzodiazepin-2-one (oxazepam) in humans. Determination of the drug by gas-liquid chromatography with electron capture detection. Arzneimittel-Forschung. 22:687–692.
   PubMed Web of Science ®Google Scholar
• Kosuge K, Jun Y, Watanabe H, Kimura M, Nishimoto M, Ishizaki T, Ohashi K. 2001. Effects of CYP3A4 inhibition by diltiazem on pharmacokinetics and dynamics of diazepam in relation to CYP2C19 genotype status. Drug Metab Disp. 29:1284–1289.
   PubMed Web of Science ®Google Scholar
• Kripke DF, Langer RD, Kline LE. 2012. Hypnotics' association with mortality or cancer: a matched cohort study. BMJ Open. 2:e000850.
   PubMed Web of Science ®Google Scholar
• Langner JG, Gan BK, Liu RH, Baugh LD, Chand P, Weng JL, Edwards C, Walia AS. 1991. Enzymatic digestion, solid-phase extraction, and gas chromatography/mass spectrometry of derivatized intact oxazepam in urine. Clin Chem. 37:1595–1601.
   PubMed Web of Science ®Google Scholar
• Lemke T, Williams D, Roche V. 2013. Foye's principles of medicinal chemistry. Philadelphia: Lippincott Williams & Wilkins.
   Google Scholar
• Lu XL, Guengerich FP, Yang SK. 1991. Stereoselective metabolism of prazepam and halazepam by human liver microsomes. Drug Metab Dispos. 19:637–642.
   PubMed Web of Science ®Google Scholar
• Lu XL, Yang SK. 1990. Metabolism of halazepam by rat liver microsomes: stereoselective formation and N-dealkylation of 3-hydroxyhalazepam. Chirality. 2:1–9.
   PubMed Web of Science ®Google Scholar
• Lucek RW, Coutinho CB, Cheripko JA, Ryan J, Schwartz MA. 1975. Further studies on medazepam metabolism in the rat. Drug Metab Disp. 3:297–302.
   PubMed Web of Science ®Google Scholar
• Luk S, Atayee RS, Ma JD, Best BM. 2014. Urinary diazepam metabolite distribution in a chronic pain population. J Anal Toxicol. 38:135–142.
   PubMed Web of Science ®Google Scholar
• Mahon WA, Inaba T, Umeda T, Tsutsumi E, Stone R. 1976. Biliary elimination of diazepam in man. Clin Pharmacol Ther. 19:443–450.
   PubMed Web of Science ®Google Scholar
• Malamed SF. 2018. Sedation: a guide to patient management. St. Louis: Elsevier.
   Google Scholar
• Mandrioli R, Mercolini L, Raggi MA. 2008. Benzodiazepine metabolism: an analytical perspective. Curr Drug Metab. 9:827–844.
   PubMed Web of Science ®Google Scholar
• Mandrioli R, Mercolini L, Raggi MA. 2010. Metabolism of benzodiazepine and non-benzodiazepine anxiolytic-hypnotic drugs: an analytical point of view. Curr Drug Metab. 11:815–829.
   PubMed Web of Science ®Google Scholar
• Marin SJ, Coles R, Merrell M, McMillin GA. 2008. Quantitation of benzodiazepines in urine, serum, plasma, and meconium by LC–MS–MS. J Anal Toxicol. 32:491–498.
   PubMed Web of Science ®Google Scholar
• Maurer H, Pfleger K. 1987. Identification and differentiation of benzodiazepines and their metabolites in urine by computerized gas chromatography-mass spectrometry. J Chromatogr. 422:85–101.
   PubMed Web of Science ®Google Scholar
• Meatherall R. 1994. Optimal enzymatic hydrolysis of urinary benzodiazepine conjugates. J Anal Toxicol. 18:382–384.
   PubMed Web of Science ®Google Scholar
• Melander A, Danielson K, Vessman J, Wahlin E. 1977. Bioavailability of oxazepam: absence of influence of food intake. Acta Pharmacol Toxicol. 40:584–588.
   PubMedGoogle Scholar
• Melo P, Bastos ML, Teixeira HM. 2012. Benzodiazepine stability in postmortem samples stored at different temperatures. J Anal Toxicol. 36:52–60.
   PubMed Web of Science ®Google Scholar
• Miyawaki I, Moriyasu M, Funabashi H, Yasuba M, Matsuoka N. 2003. Mechanism of clobazam-induced thyroidal oncogenesis in male rats. Toxicol Lett. 145:291–301.
   PubMed Web of Science ®Google Scholar
• Mohler H, Okada T, Heitz P, Ulrich J. 1978. Biochemical identification of the site of action of benzodiazepines in human brain by 3H-diazepam binding. Life Sci. 22:985–995.
   PubMed Web of Science ®Google Scholar
• Norman TR, Fulton A, Burrows GD, Maguire KP. 1981. Pharmacokinetics of N-desmethyldiazepam after a single oral dose of clorazepate: the effect of smoking. Eur J Clin Pharmacol. 21:229–233.
   PubMed Web of Science ®Google Scholar
• Obach RS. 2013. Pharmacologically active drug metabolites: impact on drug discovery and pharmacotherapy. Pharmacol Rev. 65578–640.
   PubMed Web of Science ®Google Scholar
• Ochs HR, Greenblatt DJ, Allen MD, Harmatz JS, Shader RI, Bodem G. 1979. Effect of age and Billroth gastrectomy on absorption of desmethyldiazepam from clorazepate. Clin Pharmacol Ther. 26:449–456.
   PubMed Web of Science ®Google Scholar
• Odar-Cederlof I, Vessman J, Alvan G, Sjoqvist F. 1977. Oxazepam disposition in uremic patients. Acta Pharmacol Toxicol. 40(Suppl 1): 52–62.
   PubMedGoogle Scholar
• Okamura T, Sugiura W, Miyazawa M. 1996. Reduction of oxazepam to desmethyldiazepam by human intestinal bacteria. Biol Pharm Bull. 19:647–648.
   PubMed Web of Science ®Google Scholar
• Ono S, Hatanaka T, Hotta H, Satoh T, Gonzalez FJ, Tsutsui M. 1996. Specificity of substrate and inhibitor probes for cytochrome P450s: evaluation of in vitro metabolism using cDNA-expressed human P450s and human liver microsomes. Xenobiotica. 26:681–693.
   PubMed Web of Science ®Google Scholar
• Ono S, Hatanaka T, Miyazawa S, Tsutsui M, Aoyama T, Gonzalez FJ, Satoh T. 1996. Human liver microsomal diazepam metabolism using cDNA-expressed cytochrome P450s: role of CYP2B6, 2C19 and the 3A subfamily. Xenobiotica. 26:1155–1166.
   PubMed Web of Science ®Google Scholar
• Ozdemir M, Aktan Y, Boydag BS, Cingi MI, Musmul A. 1998. Interaction between grapefruit juice and diazepam in humans. Eur J Drug Metab Pharmacokinet. 23:55–59.
   PubMed Web of Science ®Google Scholar
• Pacifici GM, Placidi GF. 1977. Rapid and sensitive electron-capture gas chromatographic method for the determination of pinazepam and its metabolites in human plasma, urine and milk. J Chromatogr. 135:133–139.
   PubMed Web of Science ®Google Scholar
• Pacifici GM, Placidi GF. 1982. First pass effect of pinazepam in the rabbit liver. Eur J Drug Metab Pharmacokinet. 7:119–122.
   PubMed Web of Science ®Google Scholar
• Parkinson A, Leonard N, Draper A, Ogilvie BW. 2006. On the mechanism of hepatocarcinogenesis of benzodiazepines: evidence that diazepam and oxazepam are CYP2B inducers in rats, and both CYP2B and CYP4A inducers in mice. Drug Metab Rev. 38:235–259.
   PubMed Web of Science ®Google Scholar
• Patel M, Tang BK, Kalow W. 1995. (S)oxazepam glucuronidation is inhibited by ketoprofen and other substrates of UGT2B7. Pharmacogenetics. 5:43–49.
   PubMedGoogle Scholar
• Preat V, de Gerlache J, Lans M, Roberfroid M. 1987. Promoting effect of oxazepam in rat hepatocarcinogenesis. Carcinogenesis. 8:97–100.
   PubMed Web of Science ®Google Scholar
• Ries RK, Fiellin DA, Miller SC, Saitz R. 2014. Principles of addiction medicine. Philadelphia: Wolters Kluwer.
   Google Scholar
• Rouini MR, Ardakani YH, Moghaddam KA, Solatani F. 2008. An improved HPLC method for rapid quantitation of diazepam and its major metabolites in human plasma. Talanta. 75:671–676.
   PubMed Web of Science ®Google Scholar
• Sakai N, Ishizuka M. 2009. Impact of rat P450 genetic polymorphism on diazepam metabolism. Exp Opin Drug Metab Toxicol. 5:1421–1433.
   PubMed Web of Science ®Google Scholar
• Schwartz MA, Carbone JJ. 1970. Metabolism of 14C-medazepam hydrochloride in dog, rat and man. Biochem Pharmacol. 19:343–361.
   PubMedGoogle Scholar
• Schwartz MA, Kolis SJ. 1972. Pathways of medazepam metabolism in the dog and rat. J Pharmacol Exp Ther. 180:180–188.
   PubMed Web of Science ®Google Scholar
• Schwartz MA, Postma E. 1972. Metabolites of demoxepam, a chlordiazepoxide metabolite, in man. J Pharm Sci. 61:123–125.
   PubMed Web of Science ®Google Scholar
• Schwarz HJ. 1979. Pharmacokinetics and metabolism of temazepam in man and several animal species. Br J Clin Pharmacol. 8:23s–29s.
   PubMed Web of Science ®Google Scholar
• Scott AK, Khir AS, Bewsher PD, Hawksworth GM. 1984. Oxazepam pharmacokinetics in thyroid disease. Br J Clin Pharmacol. 17:49–53.
   PubMed Web of Science ®Google Scholar
• Shader RI, Georgotas A, Greenblatt DJ, Harmatz JS, Allen MD. 1978. Impaired absorption of desmethyldiazepam from clorazepate by magnesium aluminum hydroxide. Clin Pharmacol Ther. 24:308–315.
   PubMed Web of Science ®Google Scholar
• Shader RI, Greenblatt DJ, Ciraulo DA, Divoll M, Harmatz JS, Georgotas A. 1981. Effect of age and sex on disposition of desmethyldiazepam formed from its precursor clorazepate. Psychopharmacology. 75:193–197.
   PubMed Web of Science ®Google Scholar
• Shader RI, Pary RJ, Harmatz JS, Allison S, Locniskar A, Greenblatt DJ. 1984. Plasma concentrations and clinical effects after single oral doses of prazepam, clorazepate, and diazepam. J Clin Psychiatry. 45:411–413.
   PubMed Web of Science ®Google Scholar
• Shull HJ, Wilkinson GR, Johnson R, Schenker S. 1976. Normal disposition of oxazepam in acute viral hepatitis and cirrhosis. Ann Intern Med. 84:420–425.
   PubMed Web of Science ®Google Scholar
• Sisenwine SF, Tio CO, Liu AL, Politowski JF. 1987. The metabolic fate of oxazepam in mice. Drug Metab Disp. 15:579–580.
   PubMed Web of Science ®Google Scholar
• Sisenwine SF, Tio CO, Ruelius HW. 1970. The metabolic transformation of oxazepam in man, pig and rat. Pharmacologist. 22:272.
   Google Scholar
• Sisenwine SF, Tio CO, Shrader SR, Ruelius HW. 1972. The biotransformation of oxazepam (7-chloro-1,3-dihydro-3-hydroxy-5-phenyl-2H-1,4-benzodiazepin-2-one) in man, miniature swine and rat. Arzneimittel-Forschung. 22:682–687.
   PubMed Web of Science ®Google Scholar
• Sisenwine SF, Tio CO. 1986. The metabolic disposition of oxazepam in rats. Drug Metab Disp. 14:41–45.
   PubMed Web of Science ®Google Scholar
• Sjodin T, Roosdorp N, Sjoholm I. 1976. Studies on the binding of benzodiazepines to human serum albumin by circular dichroism measurements. Biochem Pharmacol. 25:2131–2140.
   PubMed Web of Science ®Google Scholar
• Smink BE, Hofman BJ, Dijkhuizen A, Lusthof KJ, de Gier JJ, Egberts AC, Uges DR. 2008. The concentration of oxazepam and oxazepam glucuronide in oral fluid, blood and serum after controlled administration of 15 and 30 mg oxazepam. Br J Clin Pharmacol. 66:556–560.
   PubMed Web of Science ®Google Scholar
• Sonne J, Boesgaard S, Poulsen HE, Loft S, Hansen JM, Dossing M, Andreasen F. 1990. Pharmacokinetics and pharmacodynamics of oxazepam and metabolism of paracetamol in severe hypothyroidism. Br J Clin Pharmacol. 30:737–742.
   PubMed Web of Science ®Google Scholar
• Sonne J, Loft S, Dossing M, Vollmer-Larsen A, Olesen KL, Victor M, Andreasen F, Andreasen PB. 1988. Bioavailability and pharmacokinetics of oxazepam. Eur J Clin Pharmacol. 35:385–389.
   PubMed Web of Science ®Google Scholar
• Stebler T, Guentert TW. 1991. Determination of diazepam and nordazepam in milk and plasma in the presence of oxazepam and temazepam. J Chromatogr. 564:330–337.
   PubMed Web of Science ®Google Scholar
• Sternbach LH, Reeder E. 1961. Quinazolines and 1,4-benzodiazepines. II.1 the rearrangement of 6-chloro-2-chloromethyl-4-phenylquinazoline 3-oxide into 2-amino derivatives of 7-chloro-5-phenyl-3H-1,4-benzodiazepine 4-oxide. J Org Chem. 26:1111–1118.
   Web of Science ®Google Scholar
• Troupin AS, Friel P, Wilensky AJ, Morretti-Ojemann L, Levy RH, Feigl P. 1979. Evaluation of clorazepate (Tranxene) as an anticonvulsant-a pilot study. Neurology. 29:458–466.
   PubMed Web of Science ®Google Scholar
• Valavani P, Atta-Politou J, Panderi I. 2005. Development and validation of a liquid chromatographic/electrospray ionization mass spectrometric method for the quantitation of prazepam and its main metabolites in human plasma. J Mass Spectrom. 40:516–526.
   PubMed Web of Science ®Google Scholar
• Vida AJ. 1977. Anticonvulsants. New York: Academic Press.
   Google Scholar
• Walkenstein SS, Wiser R, Gudmundsen CH, Kimmel HB, Corradino RA. 1964. Absorption, metabolism, and excretion of oxazepam and its succinate half-ester. J Pharm Sci. 53:1181–1186.
   PubMed Web of Science ®Google Scholar
• Wilensky AJ, Levy RH, Troupin AS, Moretti-Ojemann L. 1978. Clorazepate kinetics in treated epileptics. Clin Pharmacol Ther. 24:22–30.
   PubMed Web of Science ®Google Scholar
• Wretlind M. 1987. Excretion of oxazepam in breast milk. Eur J Clin Pharmacol. 33:209–210.
   PubMed Web of Science ®Google Scholar
• Wu F, Marin SJ, McMillin GA. 2016. Stability of 21 cocaine, opioid and benzodiazepine drug analytes in spiked meconium at three temperatures. J Anal Toxicol. 41:196–204.
   Web of Science ®Google Scholar
• Yang SK, Bao Z, Shou M. 1996. Stereoselective nucleophilic substitution of oxazepam and racemization in acidic methanol and ethanol. Chirality. 8:214–223.
   PubMed Web of Science ®Google Scholar
• Yang SK, Lu XL. 1989. Racemization kinetics of enantiomeric oxazepams and stereoselective hydrolysis of enantiomeric oxazepam 3-acetates in rat liver microsomes and brain homogenate. J Pharm Sci. 78:789–795.
   PubMed Web of Science ®Google Scholar
• Yang TJ, Krausz KW, Shou M, Yang SK, Buters JT, Gonzalez FJ, Gelboin HV. 1998. Inhibitory monoclonal antibody to human cytochrome P450 2B6. Biochem Pharmacol. 55:1633–1640.
   PubMed Web of Science ®Google Scholar